Cargando…

Nanoparticles as Drug Delivery Systems of RNAi in Cancer Therapy

RNA interference (RNAi) can mediate gene-silencing by knocking down the expression of a target gene via cellular machinery with much higher efficiency in contrast to other antisense-based approaches which represents an emerging therapeutic strategy for combating cancer. Distinct characters of nanopa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Diedie, Gao, Chengzhi, Kuang, Meiyan, Xu, Minhao, Wang, Ben, Luo, Yi, Teng, Lesheng, Xie, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073355/ https://www.ncbi.nlm.nih.gov/pubmed/33921892 http://dx.doi.org/10.3390/molecules26082380

Ejemplares similares

Nanotechnology and Microtechnology in Drug Delivery Systems
por: Sun, Jingyao, et al.
Publicado: (2020)

Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy
por: Jia, Ruixin, et al.
Publicado: (2021)

Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes
por: Rivera Díaz, Mónica, et al.
Publicado: (2013)

Smart drug delivery systems for precise cancer therapy
por: Wang, Xiaoyou, et al.
Publicado: (2022)

Triggering RNAi with multifunctional RNA nanoparticles and their delivery
por: Dao, Bich Ngoc, et al.
Publicado: (2015)

Microfluidics for nano-drug delivery systems: From fundamentals to industrialization
por: Zhang, Huan, et al.
Publicado: (2023)

Oral delivery of RNAi for cancer therapy
por: Afrin, Humayra, et al.
Publicado: (2023)

Nanoemulsion Co-Loaded with XIAP siRNA and Gambogic Acid for Inhalation Therapy of Lung Cancer
por: Xu, Minhao, et al.
Publicado: (2022)

Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
por: Zhou, Jiehua, et al.
Publicado: (2013)

Microfluidic hydrodynamic focusing synthesis of polymer-lipid nanoparticles for siRNA delivery
por: Huang, Xueqin, et al.
Publicado: (2017)

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
por: Lage, Hermann, et al.
Publicado: (2010)

Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics
por: Gentile, Emanuela, et al.
Publicado: (2017)

Nano-based delivery of RNAi in cancer therapy
por: Xin, Yong, et al.
Publicado: (2017)

In Vivo Delivery of RNAi by Reducible Interfering Nanoparticles (iNOPs)
por: Baigude, Huricha, et al.
Publicado: (2013)

Calcium Phosphate Nanoparticles-Based Systems for RNAi Delivery: Applications in Bone Tissue Regeneration
por: Levingstone, Tanya J., et al.
Publicado: (2020)

Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation
por: Sun, Yating, et al.
Publicado: (2017)

Nanoparticle drug delivery systems for synergistic delivery of tumor therapy
por: Chen, Daoyuan, et al.
Publicado: (2023)

A novel therapeutic strategy for cartilage diseases based on lipid nanoparticle-RNAi delivery system
por: Wang, Shaowei, et al.
Publicado: (2018)

Synthesis of Polymer-Lipid Nanoparticles by Microfluidic Focusing for siRNA Delivery
por: Li, Yujing, et al.
Publicado: (2016)

Cyclic RGD Peptide Targeting Coated Nano Drug Co-Delivery System for Therapeutic Use in Age-Related Macular Degeneration Disease
por: Liu, Jiaxin, et al.
Publicado: (2020)

Recent progress on nanoparticle-based drug delivery systems for cancer therapy
por: Xin, Yanru, et al.
Publicado: (2017)

Mucosal Delivery of RNAi Therapeutics
por: González, Borja Ballarín, et al.
Publicado: (2012)

Nanoparticle-based drug delivery systems for cancer therapy
por: Dang, Yu, et al.
Publicado: (2020)

Exosomes as smart drug delivery vehicles for cancer immunotherapy
por: Zhang, Huan, et al.
Publicado: (2023)

Novel RNAi delivery systems in the control of medical and veterinary pests
por: Whitten, Miranda MA
Publicado: (2019)

Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract
por: Zhang, Yuan, et al.
Publicado: (2022)

Delivery of RNAi-Based Oligonucleotides by Electropermeabilization
por: Chabot, Sophie, et al.
Publicado: (2013)

Delivery Methods for RNAi in Mosquito Larvae
por: Munawar, Kashif, et al.
Publicado: (2020)

Targeted Co-Delivery of siRNA and Methotrexate for Tumor Therapy via Mixed Micelles
por: Hao, Fei, et al.
Publicado: (2019)

Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation
por: Qu, Na, et al.
Publicado: (2019)

Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
por: Lohcharoenkal, Warangkana, et al.
Publicado: (2014)

Advances in Nanoparticle Drug Delivery Systems for Anti-Hepatitis B Virus Therapy: A Narrative Review
por: Miao, Jing, et al.
Publicado: (2021)

RNAi for research and therapy
por: Goldman, Michael A
Publicado: (2004)

Nanoparticles in Ocular Drug Delivery Systems
por: Almeida, Hugo, et al.
Publicado: (2023)

Editorial: Drug Delivery System Based on Nanoparticles for Inflammation and Cancer Therapy
por: Zhang, Mingxin, et al.
Publicado: (2022)

A Polyethylenimine-Linoleic Acid Conjugate for Antisense Oligonucleotide Delivery
por: Xie, Jing, et al.
Publicado: (2013)

Silk Fibroin-Based Nanoparticles for Drug Delivery
por: Zhao, Zheng, et al.
Publicado: (2015)

Baculovirus-mediated Gene Delivery and RNAi Applications
por: Makkonen, Kaisa-Emilia, et al.
Publicado: (2015)

RNAi Trigger Delivery into Anopheles gambiae Pupae
por: Regna, Kimberly, et al.
Publicado: (2016)

Protein-based vehicles for biomimetic RNAi delivery
por: Pottash, Alex Eli, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_puicjo3rdq5to60601f1mt1rfv